Announcement PDF 15091 AL Hwy 20 Madison, AL 35756 ABN: 77 602 793 644 info@titomic.com | titomic.com ASX Announcement October 21, 2026 Registration of Scheme Booklet with ASIC HUNTSVILLE, AL – Titomic Limited (ASX: TTT), a global advanced manufacturing company serving the U.S. and allied defense industrial base, using its proprietary cold spray Titomic Kinetic Fusion™ (TKF)™ Technology, is pleased to provide an update in relation to the scheme of arrangement between Titomic and its shareholders (the “Scheme”), pursuant to which Titomic, Inc. (“Titomic US HoldCo”) will acquire 100% of Titomic’s issued shares and Titomic US HoldCo will become the new ultimate parent company of Titomic and its subsidiaries (“Titomic Group”), re-domiciling Titomic Group to the State of Delaware in the United States. Highlights • The Federal Court of Australia made orders on Tuesday, October 20, 2026 for the convening of the Scheme Meeting and approving the dispatch of the Scheme Booklet to Titomic shareholders. • The Scheme Meeting will be held on Monday, November 23, 2026, commencing at 10:00am (Sydney time). • The Scheme Booklet has today been registered by ASIC. • The Scheme Booklet is expected to be dispatched to Titomic shareholders by Thursday, October 22, 2026. • The Independent Expert has concluded that the Scheme is in the best interests of Titomic shareholders, in the absence of an alternative proposal or any further information. • The directors of Titomic unanimously recommend that Titomic shareholders vote in favour of the Scheme, subject to the Independent Expert continuing to conclude that the Scheme is in the best interests of Titomic shareholders.1 Court orders The Federal Court of Australia made orders on Tuesday, October 20, 2026 approving: • the convening by Titomic of a meeting of Titomic shareholders to consider and vote on the Scheme (the “Scheme Meeting”); and • the dispatch of the explanatory statement providing information about the Scheme, together with a notice of meeting for the Scheme Meeting, (together, the “Scheme Booklet”) to Titomic shareholders. Chairman’s Quote Titomic Executive Chairman, Dag Stromme, stated: “The Board’s unanimous recommendation to redomicile Titomic to the United States marks a pivotal milestone in our corporate evolution. Establishing a U.S.-domiciled parent entity positions Titomic at the absolute center of the world’s largest defense and aerospace markets. “ 1 The interests of the directors of Titomic in Titomic securities are set out in section 10.1(1) of the Scheme Booklet. Titomic shareholders should have regard to these interests when considering the recommendations of the directors of Titomic in relation to the Scheme. 15091 AL Hwy 20 Madison, AL 35756 ABN: 77 602 793 644 info@titomic.com | titomic.com “Our expansion is validated by strong U.S. federal and local government support. This strategic shift coincides with strong commercial momentum, as Titomic continues to scale its relationships with the U.S. military, defense primes, and critical infrastructure sector players. This is highlighted by our recent US$5 million U.S. Air Force contract with Tinker Air Force Base, our U.S. Navy-supported orders and manufacturing initiatives with sector leaders Bechtel, Boeing, Lockheed Martin and Northrop Grumman. “ “Redomiciling to the U.S. and reshoring our supply chain establishes a robust foundation to accelerate commercial growth, expand institutional investor access, and maximize shareholder value.” Why the Board recommends the Scheme The Titomic Board believes that the Scheme places Titomic in the best position for the next phase of its growth. A U.S. domicile is expected to bring Titomic’s corporate structure into line with where it operates and where its largest commercial opportunities are. The Titomic Board unanimously recommends that Titomic shareholders vote in favour of the Scheme, subject to no superior proposal emerging and the Independent Expert continuing to conclude that the Scheme is in the best interests of Titomic shareholders. Subject to the same qualifications, each Director intends to vote the Titomic shares they hold, or that are held on their behalf, in favour of the Scheme. The key reasons for the Board’s recommendation are set out in section 2.1 of the Scheme Booklet. In summary, the Board believes the Scheme will deliver: • Greater visibility and oversight of Titomic’s U.S. defense business. Titomic works with Tier-1 prime contractors and government customers on U.S. Department of War programs, many of which involve ITAR-controlled and classified work. To be eligible for this work, Titomic will need a Facility Security Clearance (FCL) from the Defense Counterintelligence and Security Agency (DCSA). DCSA reviews FCL applications for foreign ownership, control or influence (FOCI). Titomic has already started the FCL process with the sponsorship of a U.S. Tier-1 defense prime contractor. • Direct access to the world’s largest defense market. U.S. defense procurement increasingly favors domestic supply chains and manufacturing capacity. A U.S. domicile is expected to put Titomic alongside its largest customers. • Strategic alignment with Department of War initiatives. The Scheme is expected to align Titomic with federal efforts to strengthen the defense industrial base. It is also expected to make Titomic eligible for non-dilutive funding from the U.S. Small Business Administration and the Office of Strategic Capital. • Access to deeper capital markets. A U.S.-domiciled parent is expected to give Titomic access to U.S. defense and other investors who could not, or were reluctant to, invest in a non-U.S. company, while Titomic keeps its ASX listing. • More efficient access to capital. A U.S. domicile is expected to improve Titomic’s access to lower- cost U.S. debt and to institutional and specialist equity investors in defense, aerospace and advanced manufacturing. • More strategic options. As a U.S. corporation, Titomic will be better placed to pursue merger, sale or acquisition opportunities and a potential U.S. initial public offering and listing at an appropriate time. Titomic’s global footprint will stay in place. Australia will remain Titomic’s R&D Centre of Excellence and a long-term strategic priority for the Group. Europe remains a growth market, served from Titomic’s new 22,000-square-foot automated facility in the Netherlands. 15091 AL Hwy 20 Madison, AL 35756 ABN: 77 602 793 644 info@titomic.com | titomic.com Shareholders should also consider the possible reasons to vote against the Scheme, set out in section 2.2 of the Scheme Booklet. These include: • you may disagree with the Board’s recommendation and the Independent Expert’s conclusion; • you may not wish to become a CDI holder in a U.S.-domiciled company; • the tax consequences of the Scheme may not suit your circumstances; • the trading value of the Scheme Consideration is uncertain and will depend on the price of Titomic US HoldCo CDIs on ASX on and after the Implementation Date; and • a U.S.-domiciled parent company may be exposed to more litigation. How the Scheme will work If the Scheme becomes Effective, Titomic shareholders will receive a beneficial interest in one Titomic US HoldCo share for every 25 Titomic shares held on the Record Date in the form of Titomic US HoldCo CDIs. The CDIs will be quoted on ASX under the code ‘TTT’. The Scheme must be approved by Titomic shareholders at the Scheme Meeting and by the Federal Court of Australia. Details of the Scheme Meeting The Scheme Meeting will be held virtually on Monday, November 23, 2026 via an online platform at https://meetnow.global/MQ9JZUS, commencing at 10:00am (Sydney time). Further information on, and information regarding how to participate in, the Scheme Meeting is provided in the notice of meeting for the Scheme Meeting included in the Scheme Booklet. If Titomic shareholders have additional questions about the Scheme Booklet or the Scheme, please contact the Titomic Scheme Information Line on 1300 867 053 (within Australia) or +61 3 9415 4002 (outside Australia) Monday to Friday between 8:30am and 5:00pm (Sydney time). All Titomic shareholders registered as at 7:00pm (Sydney time) on Saturday, November 21, 2026 will be eligible to vote at the Scheme Meeting. All Titomic shareholders are encouraged to vote by attending the Scheme Meeting online or by attorney or corporate representative, or alternatively by completing and ensuring the relevant proxy form accompanying the Scheme Booklet is received by Titomic’s share registry by 10:00am (Sydney time) on Saturday, November 21, 2026. Further information on how to vote at the Scheme Meeting is included in the Scheme Booklet. Scheme Booklet Titomic confirms that the Scheme Booklet has been registered with the Australian Securities and Investments Commission (“ASIC”). A copy of the Scheme Booklet is attached to this announcement and will also be made available at the following link: Titomic Investor Hub The Scheme Booklet is expected to be dispatched to Titomic shareholders by Thursday, October 22, 2026. Titomic shareholders who have previously elected to receive electronic communications from Titomic, or who have made no election on how to receive communications from Titomic but have an email address recorded in Titomic’s share register, will be sent an email containing instructions regarding how to view or download a copy of the Scheme Booklet, as well as instructions on how to lodge their proxy form for the Scheme Meeting. 15091 AL Hwy 20 Madison, AL 35756 ABN: 77 602 793 644 info@titomic.com | titomic.com Titomic shareholders who have previously elected to receive only hard-copy documents from Titomic will be sent, via post to their registered address, a hard copy of the Scheme Booklet, a personalised proxy form for the Scheme Meeting and a reply-paid envelope or an unstamped envelope return addressed to Titomic’s share registry by prepaid airmail to their postal address (for holders with a registered address outside of Australia). Titomic shareholders who have made no election as to how to receive communications from Titomic and have no email address recorded in Titomic’s share register will be sent a letter via post to their registered address containing instructions regarding accessing a copy of the Scheme Booklet, as well as instructions on how to lodge their proxy form for the Scheme Meeting and a reply-paid envelope or an unstamped envelope return addressed to the Titomic’s share registry by prepaid airmail to their postal address (for holders with a registered address outside of Australia). Titomic shareholders should carefully read the Scheme Booklet in its entirety, including the materials accompanying it, before deciding whether to vote in favour of the Scheme at the Scheme Meeting. Independent Expert’s Report and Directors’ Recommendation The Scheme Booklet includes a copy of the independent expert’s report (the “Independent Expert’s Report”) prepared by RSM Corporate Australia Pty Ltd (the “Independent Expert”), which concludes that the Scheme is in the best interests of Titomic shareholders as a whole, in the absence of an alternative proposal or any further information. The conclusion of the Independent Expert should be considered in the context of the full Independent Expert’s Report, which is included as Annexure A of the Scheme Booklet. The directors of Titomic unanimously recommend that Titomic shareholders vote in favour of the Scheme, subject to the Independent Expert continuing to conclude that the Scheme is in the best interests of Titomic shareholders.2 Subject to the same qualifications, each director of Titomic intends to vote, or cause to be voted, all Titomic shares held or controlled by, or on behalf of, them at the time of the Scheme Meeting in favour of the Scheme. Indicative timetable The key dates expected for the Scheme are set out below. Capitalised terms used in this announcement have the same meaning given to those terms in the Scheme Booklet. Event Date Dispatch of the Scheme Booklet Thursday, October 22, 2026 Proxy Form Cut-Off Date Latest time and date for Proxy Forms or powers of attorney to be received by the Titomic Share Registry for the Scheme Meeting 10:00am (Sydney time) on Saturday, November 21, 2026 Scheme Meeting Record Date Time and date for determining eligibility to vote at the Scheme Meeting 7:00pm (Sydney time) on Saturday, November 21, 2026 Scheme Meeting 10:00am (Sydney time) on Monday, November 23, 2026 2 The interests of the directors of Titomic in Titomic securities are set out in section 10.1(1) of the Scheme Booklet. Titomic shareholders should have regard to these interests when considering the recommendations of the directors of Titomic in relation to the Scheme. 15091 AL Hwy 20 Madison, AL 35756 ABN: 77 602 793 644 info@titomic.com | titomic.com Event Date If the Scheme Resolution is approved by Titomic Shareholders, the following key dates will apply: Second Court Date 2:15pm (Sydney time) on Thursday, November 26, 2026 Effective Date Court order to be lodged with ASIC and announcement to the ASX that trading in Titomic Shares is to be suspended from close of trading Friday, November 27, 2026 Titomic US HoldCo CDIs to commence trading on ASX on a deferred settlement basis Monday, November 30, 2026 Record Date Date for determining entitlements of Titomic Shareholders to the Scheme Consideration 7:00pm (Sydney time) on Tuesday, December 1, 2026 Implementation Date Scheme Consideration to be issued to Scheme Shareholders All Scheme Shares are transferred to Titomic US HoldCo Tuesday, December 8, 2026 Titomic US HoldCo CDIs to commence trading on a normal T+2 settlement basis on ASX Wednesday, December 9, 2026 Dispatch of Titomic US HoldCo CDI holding statements and confirmation advices Thursday, December 10, 2026 * Except where otherwise specified, all times and dates in the above timetable are references to the time and date in Sydney, Australia unless otherwise stated and all such times and dates are subject to change. The actual dates and times will depend on many factors outside the control of Titomic and Titomic US HoldCo, including the Court approval process and the satisfaction or waiver of the conditions precedent to the Scheme. Due to the time zone differences between Australia and the United States, certain actions relating to implementation of the Scheme may occur on Monday, December 7, 2026 during US business hours so as to enable implementation to occur on Tuesday, December 8, 2026 during Australian business hours. Any changes to the above timetable will be announced to ASX and will be available on Titomic’s website at https://titomic.com/. This announcement has been authorized for release by Titomic’s Executive Chairman. - - - - - END - - - - - Stay Connected Receive ASX announcements and company updates directly to your inbox, access video summaries, and take part in Q&A sessions with Titomic. Sign up to our Investor Hub via investors.titomic.com 15091 AL Hwy 20 Madison, AL 35756 ABN: 77 602 793 644 info@titomic.com | titomic.com ABOUT TITOMIC LIMITED Titomic Limited (ASX: TTT) is a leading Advanced manufacturing company with global operations specializing in large integrated solutions for industrial- scale metal additive manufacturing, coating, and repairs using its patented kinetic fusion cold spray (Titomic Kinetic Fusion™) technology. Titomic Kinetic Fusion™ cold spray solutions provide OEM production and R&D services to the global Aerospace, Defense, Shipbuilding, Oil & Gas, Mining and Automotive industries. Titomic also offers global sales and support for all its Titomic Kinetic Fusion™ cold spray AM activities from its Huntsville, Alabama Global Headquarters, as well as through local presence in the Australia and Europe. Titomic delivers competitive advantages in metal additive manufacturing at every stage in the product value chain. For more information, please visit www.titomic.com. FORWARD LOOKING STATEMENTS Certain statements made in this release are forward-looking statements and are based on Titomic’s current expectations, estimates and projections. Words such as “anticipates”, “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “guidance” and similar expressions are intended to identify forward-looking statements. Although Titomic believes the forward-looking statements are based on reasonable assumptions, they are subject to certain risks and uncertainties, some of which are beyond Titomic’s control, including those risks or uncertainties inherent in the process of both developing and commercializing technology. As a result, actual results could materially differ from those expressed or forecasted in the forward-looking statements. The forward-looking statements made in this release relate only to events as of the date on which the statements are made. Titomic will not undertake any obligation to release publicly any revisions or updates to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date of this release except as required by law or by any appropriate regulatory authority. INVESTOR CONTACT Geoff Hollis Chief Financial Officer P: +61 438 168 008 E: geoff.hollis@titomic.com MEDIA CONTACT Dave Rogalski Executive Vice President Strategy and Business Development P: +1 310 291 5706 E: dave.rolgalski@titomic.us SCHEME BOOKLET Titomic Limited ACN 602 793 644 SCHEME BOOKLET For the scheme of arrangement between Titomic and Titomic Shareholders in relation to the proposed re-domiciliation of Titomic Group from Australia to the State of Delaware in the United States, under which a newly formed company incorporated under the laws of the State of Delaware (Titomic, Inc.) will become the new ultimate parent company of Titomic Group. The Titomic Board unanimously recommends that you VOTE IN FAVOUR of the Scheme, in the absence of a superior proposal and subject to the Independent Expert maintaining its conclusion that the Scheme is in the best interests of Titomic Shareholders. The Independent Expert has also concluded that the Scheme is in the best interests of Titomic Shareholders as a whole in the absence of an alternative proposal or any further information. This is an important document and requires your immediate attention. You should read this document in its entirety before deciding how to vote on the Scheme. If you are in any doubt as to what you should do, you should consult your legal, financial, tax or other professional adviser immediately. If you require further information or have any questions in relation to the Scheme, please contact the Titomic Scheme Information Line on 1300 867 053 (within Australia) or +61 3 9415 4002 (outside Australia) Monday to Friday between 8:30am and 5:00pm (Sydney time). Legal adviser to Titomic IMPORTANT NOTICES THIS SCHEME BOOKLET CONTAINS IMPORTANT INFORMATION This Scheme Booklet is an important document and requires your immediate attention. You should read this Scheme Booklet carefully and in its entirety before deciding how to vote on the Scheme. PURPOSE OF THIS SCHEME BOOKLET The purpose of this Scheme Booklet is to explain the terms of the Scheme and the manner in which it will be considered and implemented (if approved by the Requisite Majority of Titomic Shareholders and by the Federal Court of Australia (the Court)) and to provide information as is prescribed or otherwise material to the decision of Titomic Shareholders regarding how to vote on the Scheme Resolution. This Scheme Booklet includes the Explanatory Statement for the Scheme required by section 412(1) of the Corporations Act and provides all information required to be given to Titomic Shareholders or that is otherwise material to the making of a decision in relation to the Scheme, being information that is within the knowledge of any Titomic Director which has not previously been disclosed to Titomic Shareholders. If you have sold all of your Titomic Shares as at the date of this Scheme Booklet, please ignore this Scheme Booklet. STATUS OF THIS SCHEME BOOKLET This Scheme Booklet is not a disclosure document required by Chapter 6D of the Corporations Act. Section 708(17) of the Corporations Act does not apply in relation to arrangements under Part 5.1 of the Corporations Act approved at a meeting held as a result of an order under section 411(1) of the Corporations Act. Instead, Titomic Shareholders asked to vote on an arrangement at such a meeting must be provided with the explanatory statement as referred to above. NO INVESTMENT ADVICE This Scheme Booklet does not constitute financial product advice and has been prepared without reference to the individual investment objectives, financial situation, taxation position or particular needs of any Titomic Shareholder or any other person. It is important that you read this Scheme Booklet carefully and in its entirety before making any decision, including deciding how to vote on the Scheme Resolution. This Scheme Booklet should not be relied upon as the sole basis for any investment decision. If you are in doubt as to what you should do, you should consult your legal, financial, tax or other professional adviser immediately. Titomic Shareholders should consult their tax adviser as to the applicable taxation consequences of the Scheme. A summary of certain United States and Australian taxation considerations is detailed in section 8. ROLE OF ASIC This Scheme Booklet includes the Explanatory Statement for the Scheme required by section 412(1) of the Corporations Act. A copy of this Scheme Booklet has been lodged with, and registered by, ASIC for the purposes of section 412(6) of the Corporations Act. ASIC has been given the opportunity to comment on this Scheme Booklet in accordance with section 411(2) (b) of the Corporations Act. Neither ASIC nor any of its officers takes any responsibility for the contents of this Scheme Booklet. ASIC has been requested to provide a statement, in accordance with section 411(17)(b) of the Corporations Act, that it has no objection to the Scheme. If ASIC provides that statement, it will be produced to the Court on the Second Court Date. ROLE OF ASX A copy of this Scheme Booklet has been lodged with ASX. Neither ASX nor any of its officers take any responsibility for the contents of this Scheme Booklet. The fact that ASX may admit Titomic US HoldCo to its official list is not to be taken in any way as an indication of the merits of Titomic US HoldCo. IMPORTANT NOTICE ASSOCIATED WITH THE COURT ORDER UNDER SECTION 411(1) OF THE CORPORATIONS ACT The fact that, under section 411(1) of the Corporations Act, the Court has ordered that the Scheme Meeting be convened and has approved the Explanatory Statement required to accompany the Notice of Scheme Meeting does not mean that the Court: (1)  has formed any view as to the merits of the proposed Scheme or as to how you should vote (on this matter, you must reach your own decision); or (2)  has prepared, or is responsible for the content of, the Explanatory Statement. NOTICE OF SCHEME MEETING The Notice of Scheme Meeting is set out in Annexure E. Further details with respect to the conduct of the Scheme Meeting, including how to attend and participate via the online platform, are outlined in the Notice of Scheme Meeting set out in Annexure E. NOTICE OF SECOND COURT HEARING At the Second Court Hearing, the Court will consider whether to approve the Scheme. Any Titomic Shareholder may appear at the Second Court Hearing, expected to be held at the Federal Court of Australia, New South Wales Registry, Law Courts Building, 184 Phillip Street, Queens Square, Sydney NSW 2000, Australia on the Second Court Date which 1 is expected to be at 2:15pm (Sydney time) on Thursday, 26 November 2026. Any Titomic Shareholder who wishes to oppose approval of the Scheme at the Second Court Hearing may do so by filing with the Court and serving on Titomic a notice of appearance in the prescribed form, together with any affidavit that the Titomic Shareholder proposes to rely on. Any changes to the date or arrangements for the conduct of the Second Court Hearing will be announced to Titomic Shareholders. DEFINED TERMS AND INTERPRETATION Capitalised terms used in this Scheme Booklet (other than in the Independent Expert Report contained in Annexure A) and the Proxy Form accompanying this Scheme Booklet are either defined in brackets when first used or are defined in the Glossary in section 11. The Glossary also sets out some rules of interpretation which apply to this Scheme Booklet. The Independent Expert Report contains its own defined terms which may be different from those set out in the Glossary in section 11. REFERENCES TO THIS SCHEME BOOKLET, SECTIONS AND ANNEXURES References to sections and Annexures are to the named sections and Annexures in this Scheme Booklet. RESPONSIBILITY STATEMENT Except as outlined below, the information contained in this Scheme Booklet has been provided by Titomic and is its responsibility alone. Except as outlined below, neither Titomic US HoldCo nor any of its respective officers, employees or advisers assume any responsibility for the accuracy or completeness of such information. The Titomic US HoldCo information has been prepared by, and is the responsibility of, Titomic US HoldCo. Neither Titomic nor any of its subsidiaries, directors, officers, employees or advisers assume any responsibility for the accuracy or completeness of such information. RSM Corporate Australia Pty Ltd has prepared, and is solely responsible for, the Independent Expert Report contained in Annexure A. Neither Titomic nor Titomic US HoldCo nor any of their respective directors, officers or advisers (other than the advisers on the basis referred to above), assume any responsibility for the accuracy or completeness of any of the information in the Independent Expert Report except, in the case of Titomic and Titomic US HoldCo respectively, in relation to the information which each of them has provided to the Independent Expert. The directors of Titomic and Titomic US HoldCo confirm that they have not obtained any other reports from independent experts for the purpose of the Scheme other than the Independent Expert Report. NOTICE TO NON-AUSTRALIAN TITOMIC SHAREHOLDERS Restrictions in foreign jurisdictions may make it impractical or unlawful for Scheme Consideration to be issued under the Scheme to, or received under the Scheme by, Titomic Shareholders in certain jurisdictions outside Australia. Titomic Shareholders (whose addresses as shown in the Titomic Share Register on the Record Date) in Australia, Austria, Belgium, Canada, China, Germany, Hong Kong, Ireland, Japan, Netherlands, New Zealand, Norway, Portugal, Singapore, Thailand, Turkey, United Arab Emirates, United Kingdom and United States will be entitled to receive this Scheme Booklet and have Scheme Consideration issued to them in accordance with the Scheme. This Scheme Booklet has not been filed with, or reviewed by, the US Securities and Exchange Commission or any United States state securities authority and none of them has passed upon or endorsed the merits of the Scheme or the accuracy, adequacy or completeness of this Scheme Booklet. Any representation to the contrary may be a criminal offence. Nominees, custodians and other Titomic Shareholders who hold Titomic Shares on behalf of a beneficial owner resident outside Australia, Austria, Belgium, Canada, China, Germany, Hong Kong, Ireland, Japan, Netherlands, New Zealand, Norway, Portugal, Singapore, Thailand, Turkey, United Arab Emirates, United Kingdom and United States may not forward this Scheme Booklet (or any accompanying document) to anyone outside these countries without the consent of Titomic. A Titomic Shareholder whose address shown in the Titomic Share Register is in a jurisdiction outside Australia, Austria, Belgium, Canada, China, Germany, Hong Kong, Ireland, Japan, Netherlands, New Zealand, Norway, Portugal, Singapore, Thailand, Turkey, United Arab Emirates, United Kingdom and United States will be deemed to be an Ineligible Foreign Holder for the purposes of the Scheme. Titomic Shareholders who are deemed to be Ineligible Foreign Holders should refer to section 4.6 for more information. NOT AN OFFER This Scheme Booklet is not a disclosure document for the purposes of Chapter 6D of the Corporations Act and does not constitute, nor contain, an offer to sell, or a solicitation of an offer to purchase, any securities in any jurisdiction in which, or to any person to whom, it would not be lawful to make such an offer or solicitation. The release, publication or distribution of this Scheme Booklet and/or the accompanying documents into jurisdictions other than Australia may be restricted by law and this Scheme Booklet and/or the accompanying documents may not be distributed or published in any jurisdiction except under circumstances which result in compliance with applicable laws and regulations. Therefore, persons into whose possession this Scheme Booklet and/or the accompanying documents come should inform themselves about, and observe, any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws and regulations of any such jurisdiction. See section 10.7 for further information on legal restrictions outside Australia on the distribution of this Scheme Booklet and participation in the Scheme. 2 NOTICE TO TITOMIC SHAREHOLDERS IN THE UNITED STATES The issuance of the Titomic US HoldCo CDIs has not been registered under the US Securities Act or the securities laws of any state or other jurisdiction of the United States. Instead, Titomic US HoldCo intends to rely on an exemption from the registration requirements of the US Securities Act provided by section 3(a)(10) of the US Securities Act in connection with the consummation of the Sche